NAV30/05/2024 Chg.0.0000 Type de rendement Focus sur l'investissement Société de fonds
4.0900USD 0.00% reinvestment Equity Sector Health / Pharma Invesco Management 

Stratégie d'investissement

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
 

Objectif d'investissement

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
 

Opérations

Type de rendement: reinvestment
Fonds Catégorie: Equity
Pays: China
Branche: Sector Health / Pharma
Benchmark: MSCI China A Onshore Health Care Index
Début de l'exercice: 29/02
Dernière distribution: -
Banque dépositaire: The Bank of New York Mellon SA/NV
Domicile: Luxembourg
Permission de distribution: Austria, Germany, Switzerland
Gestionnaire du fonds: Chris Liu, Kehong Jiang
Actif net: 486.11 Mio.  EUR
Date de lancement: 03/03/2021
Focus de l'investissement: -

Conditions

Surtaxe d'émission: 5.00%
Frais d'administration max.: 0.75%
Investissement minimum: 1,500.00 USD
Deposit fees: 0.01%
Frais de rachat: 0.00%
Prospectus simplifié: Télécharger (Version imprimée)
 

Société de fonds

Société de fonds: Invesco Management
Adresse: An der Welle 5, 60322, Frankfurt am Main
Pays: Germany
Internet: www.de.invesco.com
 

Actifs

Stocks
 
96.91%
Cash
 
3.09%

Pays

China
 
65.14%
Cash
 
3.09%
Cayman Islands
 
3.05%
Autres
 
28.72%

Branches

Pharma/Biotechnology
 
50.29%
Healthcare appliances
 
14.53%
Healthcare services
 
3.36%
Cash
 
3.09%
Autres
 
28.73%